IGF-1 Therapy Improves Muscle Size and Function in Experimental Peripheral Arterial Disease-Reference-Cited by-同舟云学术

IGF-1 Therapy Improves Muscle Size and Function in Experimental Peripheral Arterial Disease

Published:2023-06 Issue:6 Volume:8 Page:702-719
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Dong Gengfu,Moparthy Chatick,Thome Trace,Kim Kyoungrae,Yue Feng,Ryan Terence E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference82 articles.

1. Peripheral arterial disease;Conte;Heart Lung Circ,2018

2. Heart disease and stroke statistics—2014 update: a report from the American Heart Association;Go;Circulation,2014

3. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis;Fowkes;Lancet,2013

4. Critical limb ischemia: definition and natural history;Novo;Curr Drug Targets Cardiovasc Haematol Disord,2004

5. Skeletal muscle mitochondrial dysfunction and oxidative stress in peripheral arterial disease: a unifying mechanism and therapeutic target;Kim;Antioxidants (Basel),2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skeletal muscle regeneration failure in ischemic-damaged limbs is associated with pro-inflammatory macrophages and premature differentiation of satellite cells;Genome Medicine;2023-11-10

2. Activation of the Aryl Hydrocarbon Receptor in Muscle Exacerbates Ischemic Pathology in Chronic Kidney Disease;Circulation Research;2023-07-07

3. Chronic activation of the aryl hydrocarbon receptor in muscle exacerbates ischemic pathology in chronic kidney disease;2023-05-18

4. Revisiting Skeletal Muscle Dysfunction and Exercise in Chronic Obstructive Pulmonary Disease: Emerging Significance of Myokines;Aging and disease;2023